VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time).
A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
Contacts
Inquiries
Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
The post AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 appeared first on Daily Host News.
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 first appeared on Web and IT News.
Dataiku pairs Snowflake Cortex AI with Dataiku’s agentic builder, helping more customers turn business intent…
HIVE’s BUZZ HPC Announces 320 MW Sovereign AI Infrastructure in Greater Toronto Area BUZZ is…
Ford Motor shares jumped 13 percent in a single day this week. That marked the…
Developers have grown accustomed to AI assistants that spit out code at impressive speed. Yet…
SpaceX stands on the verge of the largest initial public offering in history. The rocket…
Security researchers at a small Palo Alto firm did what seemed improbable. They took an…
This website uses cookies.